Project Grant HT94252410242
Award Date 9/30/24
Completion Date 9/29/27
Dollars Obligated $1.3M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45220, USA
Similar Awards
- This federal Project Grant award of $817,828.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research conducted by the University of Cincinnati's Sponsored Research Services Division. The research project, titled "Nuclear Translocation of Mutant NE Confers G-CSF Resistance in Severe Congenital Neutropenia," aims to transform healthcare for military service members and the broader public through...
- The University of Cincinnati received a $243,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Characterization of Novel Perivascular Lesions Caused by Specific Deletion of TSC2 in Hematopoietic Cells." The award period is from May 1, 2024 to April 30, 2026. The Military Medical Research and Development program supports biomedical research aimed at improving the...
- This $1,561,794 Project Grant was awarded by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant supports research led by the University of Cincinnati to investigate the role of plasmacytoid dendritic cells (pDCs) in immune suppression and treatment resistance in acute myeloid leukemia. The award will fund a 3-year research project from September 2024 through August 2027 to advance the scientific understanding of how pDCs...
- The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...
- The Department of the Army Medical Command awarded a $161,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Regents of the University of California, San Francisco (UCSF) to conduct research on "Deciphering Translational Control of Androgen Receptor in Prostate Cancer". The grant project will run from April 1, 2024 to March 31, 2026. As a leading academic medical center and research institution, UCSF has extensive expertise in federal...
- This federal Project Grant award of $481,056, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by the University of California, Davis to investigate the role of the protein ARHGEF2 in promoting neural lineage plasticity and treatment resistance in advanced prostate cancer. The research aims to transform healthcare for military service members, veterans, and the general public by advancing the...
- This $1,844,306 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the University of Michigan to cotarget the NSD1/2 paralogs in androgen receptor (AR)-driven castration-resistant prostate cancer. The research aims to transform healthcare for military service members, veterans, and the public by developing innovative medical solutions to address critical health challenges. The project will run...
- The University of Miami received a $153,500 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENGINEERING TARGETED EXOSOME-BASED THERAPEUTICS FOR REPROGRAMMING OF CANCER-ASSOCIATED FIBROBLASTS IN TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER". The 2-year award period runs from February 15, 2024 to February 14, 2026. The Project Grant supports the university's work to develop novel...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,618,500.00 to the Regents of the University of Minnesota to conduct research titled "TARGETING EIF4F COMPLEX-DRIVEN TRANSLATION OF ONCOGENIC MRNAS IN CRPC". The 3-year award, starting on June 1, 2025, supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public....